PresentationAt this time, I would like to turn the call over to Greg Mann from Kura Oncology.At this time, I would like to welcome you to the Kura Oncology FDA approval conference call. [Operator Instructions]Greg Mann Thank you, operator. Good day to all. I'm Greg Mann, Senior Vice President, Investor Relations and Corporate Affairs at Kura Oncology. Welcome to our conference call to discuss the FDA approval of ziftomenib. Today's press release, the U.S. prescribing information and the slides we'll be revi ...